J0582 — Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
J0582 is a HCPCS Level II code for injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J0582
- Long descriptor
- Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
- Short descriptor
- Bivalirudin (endo) 1 mg
- Added
- October 1, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0582
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0582 is not quite right, the correct code is very often within a few positions of it.
- J0571Buprenorphine, oral, 1 mg
- J0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
- J0573Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
- J0574Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
- J0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
- J0576Injection, buprenorphine extended-release (brixadi), 1 mgterminated
- J0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
- J0578Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
- J0583Injection, bivalirudin, 1 mg
- J0584Injection, burosumab-twza 1 mg
- J0585Injection, onabotulinumtoxina, 1 unit
- J0586Injection, abobotulinumtoxina, 5 units
- J0587Injection, rimabotulinumtoxinb, 100 units
- J0588Injection, incobotulinumtoxin a, 1 unit
- J0589Injection, daxibotulinumtoxina-lanm, 1 unit
- J0591Injection, deoxycholic acid, 1 mg
Questions about J0582
What is HCPCS code J0582?
J0582 is a HCPCS Level II code for injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0582?
The CMS HCPCS file marks J0582 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J0582 paid under the physician fee schedule?
J0582 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).